The new Incucyte S3 will allow in vitro high-throughput functional analysis under normal and genetically or pharmacologically perturbation conditions in the field of cancer genetics as well as rare diseases. This device is highly needed to meet the increasing demand of the existing Incucyte platform by both existing and new users. In addition, it will enable us to implement new applications such as organoid cultures to accelerate multiple ongoing research projects.